Yuag, Qiana Mae .
HRN: 29-27-82 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/08/2026
AMPICILLIN 250MG (VIAL)
07/08/2026
07/14/2026
IV
160mg
Q12
MAP
Checking Initial Appropriateness
07/08/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/08/2026
07/14/2026
IV
48mg
Q24
MAP
Checking Initial Appropriateness
07/12/2026
CEFTAZIDIME 1GM (VIAL)
07/12/2026
07/19/2026
IVTT
160mg
Q12h
MAP, PSNB
Checking Final Appropriateness